Nature Communications · 7 July 2026 · From issue 03

Combining two immune drugs worked better than one drug against lung cancer that spread to the brain.

Kazutaka Hosoya, Hiroaki Ozasa et al., Anti-PD-1 plus anti-CTLA-4 blockade overcomes immune exclusion in NSCLC brain metastases by enhancing CD8+ T cell responses and promoting tertiary lymphoid structure formation, Nature Communications.

Integrity screen: passed (3 checks) Checked 8 July 2026. Read the source

The plain-language reading of this paper is in the full issue, for subscribers.

Read the full issue

Get it free, every two days

Five papers free every issue, about 15 emails a month. No spam. Leave in one click.

Also in issue 03 10 papers

A double-acting HIV antibody was safe and well tolerated in its first human trial.
Nature Medicine
Losing one gene lets lung cancer tumors resist chemotherapy, but blocking sugar uptake reverses this.
Nature Communications
Northern swallow populations shifted nesting earliest but still lost the most birds.
Proceedings of the National Academy of Sciences
Support cells in the brain first resist a tumor, then get killed, letting it grow fast.
Proceedings of the National Academy of Sciences
Where people naturally look matches how sharp and large their brain's face or word areas are.
Nature Human Behaviour
A common way to read the Paris climate goal could quietly allow more warming over time.
Nature Climate Change
Young children are kinder when they answer fast, but this fades as they grow up.
Nature Human Behaviour
Uneven atom layers make it easier for this material to flip its charge.
Science
A magnet based on orbital flow boosted a resistance effect 70 times more than a normal magnet.
Science